Nateglinide is a medicine used to help control blood sugar levels in people with Type 2 diabetes. It works by telling the pancreas to release more insulin when needed. It's taken before meals to help manage sugar levels.
Every report comes from a Lived member, sent anonymously.
Have you tried Nateglinide for Type 2 Diabetes?
Nateglinide is a prescription tablet that helps lower blood sugar in adults with type 2 diabetes. It is used alongside healthy eating and physical activity, either on its own or together with another diabetes medicine such as metformin. It was originally sold under the brand name Starlix, which has been discontinued in the US; nateglinide is now available as a generic. Nateglinide belongs to a small group of medicines called glinides (also known as meglitinides). It is not used for type 1 diabetes or for diabetic ketoacidosis, a dangerous buildup of acids in the blood that happens when the body has too little insulin. Because each dose is taken with a meal and acts for a short time, it is aimed mainly at the rise in blood sugar that follows eating.
Insulin is the hormone that moves sugar from the blood into the body's cells. In type 2 diabetes, the pancreas often cannot release enough insulin quickly enough when blood sugar climbs after a meal. Nateglinide acts on the insulin-producing cells of the pancreas, prompting them to release a burst of insulin shortly after the tablet is taken. The effect starts quickly and wears off within a few hours, which is why the tablet is taken just before eating: it is meant to cover the rise in blood sugar that follows each meal. The amount of insulin it triggers is greater when blood sugar is high and smaller when blood sugar is low. Because it depends on the pancreas still making insulin, it does not work for type 1 diabetes. Nateglinide works on the same pancreatic target as sulfonylureas such as glyburide, but it is a different type of medicine with a shorter action.
Nateglinide comes as 60 mg and 120 mg tablets. It is usually taken three times a day, 1 to 30 minutes before each main meal. The usual dose is 120 mg before meals; a lower 60 mg dose may be used for people whose blood sugar is already close to their goal when treatment starts. The dose is tied to eating. If you skip a meal, skip that meal's dose too. Taking it without food can drive blood sugar too low. Your prescriber will explain how to fit the tablets around your usual meals and what to do on days when your eating pattern changes.
The most important side effect is low blood sugar (hypoglycemia). In the clinical trials it was uncommon, but it becomes more likely when a meal is skipped or delayed, after more physical activity than usual, after drinking alcohol, or when nateglinide is combined with other diabetes medicines. Low blood sugar usually comes on quickly and can make you feel shaky, sweaty, hungry, dizzy, irritable or confused, or give you a fast heartbeat. If you notice these signs, check your blood sugar if you can; if it is below 70 mg/dL (milligrams per deciliter) or below the target your care team gave you, take 15 to 20 grams of fast sugar, such as four glucose tablets or half a cup of regular fruit juice, then recheck. Tell your care team if low blood sugar happens more than occasionally, since the dose or plan may need to change. Severe low blood sugar can cause seizures or loss of consciousness and can be life-threatening. If someone taking nateglinide passes out, has a seizure or cannot safely swallow, family or friends should give glucagon if one has been prescribed and call 911. Other side effects reported more often than with placebo include cold-like upper respiratory infections, flu-like symptoms, back pain, joint pain, dizziness and diarrhea. Modest weight gain is also possible, averaging about 1 to 1.6 kg (roughly 2 to 3.5 pounds) in trials. Rarely, people have developed rash, itching or hives, or liver problems; yellowing of the skin or eyes should be reported to the prescriber promptly.
Many medicines can change how strongly nateglinide lowers blood sugar. Other diabetes medicines and alcohol add to the risk of low blood sugar. Some medicines slow how the liver clears nateglinide, including fluconazole and voriconazole (antifungal medicines) and amiodarone (a heart rhythm medicine), which can also push blood sugar lower. Others, such as corticosteroids like prednisone, some diuretics (water pills), thyroid medicine and rifampin (an antibiotic), can raise blood sugar and make nateglinide less effective. Some supplements, including St. John's wort, can also have an effect. Share a full list of prescriptions, over-the-counter medicines and supplements with your prescriber and pharmacist, especially when something is started or stopped. Beta-blockers, often used for blood pressure or heart conditions, can hide the warning signs of low blood sugar, such as a racing heart or shakiness. Warning signs can also be weaker in people who have had diabetes for many years, have nerve damage from diabetes or have frequent low blood sugar. More frequent blood sugar checks are usually recommended in these situations. Nateglinide has not been studied in moderate to severe liver disease and is used with caution there. It is not recommended while breastfeeding because it could lower a baby's blood sugar. Information on use during pregnancy is limited; anyone pregnant or planning a pregnancy should review their diabetes treatment with their care team, since well-controlled blood sugar matters for both parent and baby.
Nateglinide begins working with the first dose, and its effect shows most clearly in blood sugar readings taken after meals. The fuller picture comes from the HbA1c (hemoglobin A1c), a blood test that reflects average blood sugar over the past two to three months. In clinical trials lasting six months, nateglinide alone lowered HbA1c by roughly half to three quarters of a percentage point more than a placebo, and adding it to metformin produced a further drop of a similar size. That is a smaller effect than many other diabetes medicines, and in one trial people switched to nateglinide from glyburide ended up with higher blood sugar. Studies have not shown that nateglinide reduces the risk of heart attack or stroke. Your care team will usually check your HbA1c every few months and may ask you to check blood sugar at home, especially at first. If blood sugar does not reach its goal, the plan may change to a higher dose, an added medicine or a different treatment. Type 2 diabetes often changes over time, so needing to adjust treatment later is common and does not mean you did something wrong. Do not stop or change nateglinide without talking with your prescriber.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Nateglinide, what you've noticed, or ask the community a question.